Yes, the FDA is allowing Elon Musk’s Neuralink to begin human trials
Share this

Neuralink is beginning to test the company’s brain implant on people. We VERIFY the steps that companies have to take in order to conduct human clinical trials.

In December 2022, billionaire Elon Musk said his company Neuralink was seeking permission from U.S. regulators to test its brain implant in people. 

The tech company is developing brain-computer interfaces (BCIs), which “allow people to control machines using their thoughts,” according to the Government Accountability Office (GAO). For example, the technology could help people with paralysis regain control of their limbs, the GAO says.

A viral post shared on X, formerly known as Twitter, on Sept. 20 claims Neuralink received approval from the U.S. Food and Drug Administration (FDA) to begin human trials. The post led to debates over the product and whether it should be allowed to be tested in people. 


Is the FDA allowing Neuralink to begin human trials?



This is true.

Yes, the FDA is allowing Neuralink to begin human trials. 


The FDA is allowing Neuralink to test its brain implant on humans. This doesn’t mean the device has received full FDA approval – that could only happen after the FDA reviews data from clinical trials. 

Neuralink announced on May 25, 2023, that the company received the FDA’s permission to launch its “first in-human clinical study.”

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the company said in a post on X.

More recently, Neuralink shared that it is recruiting patients for the human clinical trial. The company said in a Sept. 19 blog post that its Precise Robotically Implanted Brain-Computer Interface, or PRIME, study also received approval from an independent institutional review board and its first hospital site.

Clinical studies of “significant risk devices” like implants require prior approval from both the FDA and an Institutional Review Board (IRB), the FDA says on its website. 

The FDA allows clinical studies to move forward after it has received and approved an “investigational device exemption” (IDE) application. Neuralink said in its blog post that the FDA awarded the company an IDE in May 2023. 

An IDE allows an investigational device “to be used in a clinical study in order to collect safety and effectiveness data,” according to the FDA. 

This is not the same as full FDA approval of the device, which is a more lengthy process. After a device is tested on people to make sure it’s safe and effective, the FDA reviews data in order to make a decision on whether or not to approve it. 

While the FDA does not typically confirm approvals of human clinical trials, the agency provided a statement to VERIFY acknowledging Neuralink’s announcement. 

“The FDA acknowledges and understands that Neuralink has announced that its investigational device exemption (IDE) for its study of its implant/R1 robot was approved by the FDA and that it may now begin conducting human clinical trials for its device,” a spokesperson said.

Neuralink said its study aims to evaluate the safety and effectiveness of the company’s N1 brain implant and software, as well as a surgical robot. It will take approximately six years to complete, according to a study brochure. 

During the study, Neuralink’s R1 Robot will surgically place the implant “in a region of the brain that controls movement intention.” The implant is “cosmetically invisible” once it’s in place, and is “intended to record and transmit brain signals wirelessly to an app that decodes movement intention,” the company says. 

Neuralink is looking to recruit study participants who are at least 22 years old, and have either quadriplegia due to spinal cord injury or amyotrophic lateral sclerosis (ALS).

“The initial goal of our BCI is to grant people the ability to control a computer cursor or keyboard using their thoughts alone,” Neuralink said in its blog post. 

Musk said in a Sept. 20 post on X that the Neuralink device “ultimately has the potential to restore full body movement.” 

Neuralink has faced criticism from animal rights groups about how it tests its products. 

A nonprofit group, the Physicians Committee for Responsible Medicine, which among other causes advocates against animal testing, has lodged multiple complaints involving Neuralink and its treatment of monkeys and other animal subjects.

The company did admit in a February 2022 blog post that some monkeys have died during animal testing. 

The VERIFY team works to separate fact from fiction so that you can understand what is true and false. Please consider subscribing to our daily newsletter, text alerts and our YouTube channel. You can also follow us on Snapchat, Twitter, Instagram, Facebook and TikTok. Learn More »

Follow Us

Want something VERIFIED?

Text: 202-410-8808

Share this
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Russia’s Supreme Court effectively outlaws LGBTQ+ activism in a landmark ruling

MOSCOW – Russia’s Supreme Court effectively outlawed LGBTQ+ activism on Thursday, in…

Ex-Netflix worker Michael Latt found shot dead after ‘female suspect Jameelah Elena Michl broke into his home’

THE suspect accused in the slaying of an ex-Netflix worker has been…

Martin Lewis reveals how everyone with a bank account can quadruple their interest rate (and even get free cash!)

Martin Lewis has revealed how bank account holders can ‘quadruple’ their interest…

Tributes from world leaders praise Henry Kissinger as a 'giant of history' including China, which hails him as a 'good friend': 'The world has lost a great diplomat'

Tributes have come in from around the world praising Henry Kissinger, who…

Drug to Lengthen Dogs’ Lifespans Clears ‘Key’ FDA Hurdle

An experimental drug that could lengthen the lifespan of larger dogs and…

Jerusalem shooting horror: Terrifying moment three people including woman, 24, and man in his 70s are killed and eight others wounded when two Hamas brothers open fire on a bus stop before being 'neutralised'

Three people have been killed and seven wounded in a shooting carried…

Omid Scobie says names of two 'royal racists' in Endgame's Dutch translation have been 'known for a long time' and insists he 'never submitted book with them in it'

Omid Scobie has brushed off the naming of two royals as alleged…

‘The Tinder Swindler’ Producer Behind ‘Dead In The Water’ True Crime Series For Prime Video

Amazon Prime Video is delving deeper into the true crime mystery game.…

Wells Fargo refused to give me $8,000 lost from my account back – proof that we had been victim of a crime wasn’t enough

A CUSTOMER at Wells Fargo has claimed that the financial institution refused…

Iceland volcano: 150 quakes in hours cause ground to SINK as experts fear eruption will blow under famous Blue Lagoon

HUNDREDS of earthquakes have caused the ground in Iceland to sink as…

The loving family behind Shane MacGowan: The Pogues' frontman – who lost his mother to a horrific New Year's Day car crash in 2017 – owed his career to his relatives, including his 'muse' wife, loving sister and the 'hero' uncle who inspired him

Shane MacGowan died surrounded by those who had loved and supported him throughout…

Lloyds axes another 45 bank branches, bringing total number shut this year to 623 in new blow to Britain's beleaguered high street… so are any near YOU?

Lloyds Banking Group is shutting another 45 bank branches across its network amid…